The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global High Throughput Screening (HTS) Market Research Report 2024
Synopsis
The global High Throughput Screening (HTS) market was valued at US$ 15570 million in 2023 and is anticipated to reach US$ 23230 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for High Throughput Screening (HTS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High Throughput Screening (HTS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for High Throughput Screening (HTS) in Drug Discovery Programs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of High Throughput Screening (HTS) include Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc., Tecan Group Ltd., Merck Millipore, Bio-Rad Laboratories, Hamilton Company and Axxam S.p.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for High Throughput Screening (HTS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Throughput Screening (HTS).
Report Scope
The High Throughput Screening (HTS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High Throughput Screening (HTS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High Throughput Screening (HTS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies, Inc.
Danaher Corporation
Thermofisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group Ltd.
Merck Millipore
Bio-Rad Laboratories
Hamilton Company
Axxam S.p.A.
Aurora Biomed
Segment by Type
Cell-based Assays
3D - Cell Cultures
Ultra High Throughput Screening
Segment by Application
Drug Discovery Programs
Chemical Biology Programs
Biochemical Screening
Cell- & Organ-based Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Throughput Screening (HTS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global High Throughput Screening (HTS) market was valued at US$ 15570 million in 2023 and is anticipated to reach US$ 23230 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for High Throughput Screening (HTS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High Throughput Screening (HTS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for High Throughput Screening (HTS) in Drug Discovery Programs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of High Throughput Screening (HTS) include Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc., Tecan Group Ltd., Merck Millipore, Bio-Rad Laboratories, Hamilton Company and Axxam S.p.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for High Throughput Screening (HTS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Throughput Screening (HTS).
Report Scope
The High Throughput Screening (HTS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High Throughput Screening (HTS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High Throughput Screening (HTS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies, Inc.
Danaher Corporation
Thermofisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group Ltd.
Merck Millipore
Bio-Rad Laboratories
Hamilton Company
Axxam S.p.A.
Aurora Biomed
Segment by Type
Cell-based Assays
3D - Cell Cultures
Ultra High Throughput Screening
Segment by Application
Drug Discovery Programs
Chemical Biology Programs
Biochemical Screening
Cell- & Organ-based Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Throughput Screening (HTS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Throughput Screening (HTS) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell-based Assays
1.2.3 3D - Cell Cultures
1.2.4 Ultra High Throughput Screening
1.3 Market by Application
1.3.1 Global High Throughput Screening (HTS) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery Programs
1.3.3 Chemical Biology Programs
1.3.4 Biochemical Screening
1.3.5 Cell- & Organ-based Screening
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global High Throughput Screening (HTS) Market Perspective (2019-2030)
2.2 High Throughput Screening (HTS) Growth Trends by Region
2.2.1 Global High Throughput Screening (HTS) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 High Throughput Screening (HTS) Historic Market Size by Region (2019-2024)
2.2.3 High Throughput Screening (HTS) Forecasted Market Size by Region (2025-2030)
2.3 High Throughput Screening (HTS) Market Dynamics
2.3.1 High Throughput Screening (HTS) Industry Trends
2.3.2 High Throughput Screening (HTS) Market Drivers
2.3.3 High Throughput Screening (HTS) Market Challenges
2.3.4 High Throughput Screening (HTS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High Throughput Screening (HTS) Players by Revenue
3.1.1 Global Top High Throughput Screening (HTS) Players by Revenue (2019-2024)
3.1.2 Global High Throughput Screening (HTS) Revenue Market Share by Players (2019-2024)
3.2 Global High Throughput Screening (HTS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High Throughput Screening (HTS) Revenue
3.4 Global High Throughput Screening (HTS) Market Concentration Ratio
3.4.1 Global High Throughput Screening (HTS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Throughput Screening (HTS) Revenue in 2023
3.5 High Throughput Screening (HTS) Key Players Head office and Area Served
3.6 Key Players High Throughput Screening (HTS) Product Solution and Service
3.7 Date of Enter into High Throughput Screening (HTS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High Throughput Screening (HTS) Breakdown Data by Type
4.1 Global High Throughput Screening (HTS) Historic Market Size by Type (2019-2024)
4.2 Global High Throughput Screening (HTS) Forecasted Market Size by Type (2025-2030)
5 High Throughput Screening (HTS) Breakdown Data by Application
5.1 Global High Throughput Screening (HTS) Historic Market Size by Application (2019-2024)
5.2 Global High Throughput Screening (HTS) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America High Throughput Screening (HTS) Market Size (2019-2030)
6.2 North America High Throughput Screening (HTS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America High Throughput Screening (HTS) Market Size by Country (2019-2024)
6.4 North America High Throughput Screening (HTS) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High Throughput Screening (HTS) Market Size (2019-2030)
7.2 Europe High Throughput Screening (HTS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe High Throughput Screening (HTS) Market Size by Country (2019-2024)
7.4 Europe High Throughput Screening (HTS) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High Throughput Screening (HTS) Market Size (2019-2030)
8.2 Asia-Pacific High Throughput Screening (HTS) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific High Throughput Screening (HTS) Market Size by Region (2019-2024)
8.4 Asia-Pacific High Throughput Screening (HTS) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High Throughput Screening (HTS) Market Size (2019-2030)
9.2 Latin America High Throughput Screening (HTS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America High Throughput Screening (HTS) Market Size by Country (2019-2024)
9.4 Latin America High Throughput Screening (HTS) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High Throughput Screening (HTS) Market Size (2019-2030)
10.2 Middle East & Africa High Throughput Screening (HTS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa High Throughput Screening (HTS) Market Size by Country (2019-2024)
10.4 Middle East & Africa High Throughput Screening (HTS) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Detail
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. High Throughput Screening (HTS) Introduction
11.1.4 Agilent Technologies, Inc. Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation High Throughput Screening (HTS) Introduction
11.2.4 Danaher Corporation Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.2.5 Danaher Corporation Recent Development
11.3 Thermofisher Scientific, Inc.
11.3.1 Thermofisher Scientific, Inc. Company Detail
11.3.2 Thermofisher Scientific, Inc. Business Overview
11.3.3 Thermofisher Scientific, Inc. High Throughput Screening (HTS) Introduction
11.3.4 Thermofisher Scientific, Inc. Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.3.5 Thermofisher Scientific, Inc. Recent Development
11.4 PerkinElmer, Inc.
11.4.1 PerkinElmer, Inc. Company Detail
11.4.2 PerkinElmer, Inc. Business Overview
11.4.3 PerkinElmer, Inc. High Throughput Screening (HTS) Introduction
11.4.4 PerkinElmer, Inc. Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.4.5 PerkinElmer, Inc. Recent Development
11.5 Tecan Group Ltd.
11.5.1 Tecan Group Ltd. Company Detail
11.5.2 Tecan Group Ltd. Business Overview
11.5.3 Tecan Group Ltd. High Throughput Screening (HTS) Introduction
11.5.4 Tecan Group Ltd. Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.5.5 Tecan Group Ltd. Recent Development
11.6 Merck Millipore
11.6.1 Merck Millipore Company Detail
11.6.2 Merck Millipore Business Overview
11.6.3 Merck Millipore High Throughput Screening (HTS) Introduction
11.6.4 Merck Millipore Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.6.5 Merck Millipore Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories High Throughput Screening (HTS) Introduction
11.7.4 Bio-Rad Laboratories Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Hamilton Company
11.8.1 Hamilton Company Company Detail
11.8.2 Hamilton Company Business Overview
11.8.3 Hamilton Company High Throughput Screening (HTS) Introduction
11.8.4 Hamilton Company Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.8.5 Hamilton Company Recent Development
11.9 Axxam S.p.A.
11.9.1 Axxam S.p.A. Company Detail
11.9.2 Axxam S.p.A. Business Overview
11.9.3 Axxam S.p.A. High Throughput Screening (HTS) Introduction
11.9.4 Axxam S.p.A. Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.9.5 Axxam S.p.A. Recent Development
11.10 Aurora Biomed
11.10.1 Aurora Biomed Company Detail
11.10.2 Aurora Biomed Business Overview
11.10.3 Aurora Biomed High Throughput Screening (HTS) Introduction
11.10.4 Aurora Biomed Revenue in High Throughput Screening (HTS) Business (2019-2024)
11.10.5 Aurora Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
